Syros Pharmaceuticals, Inc.
COMPOSITIONS OF CYCLIN DEPENDENT KINASE 7 (CDK7) INHIBITOR
Last updated:
Abstract:
The present invention provides, in part, compositions comprising an inhibitor of cyclin-dependent kinase 7 (CDK7) and sulfobutyl ether-.beta.-cyclodextrin. Also provided are methods of using a disclosed composition for treating proliferative diseases. The present invention also provides methods of making disclosed compositions.
Status:
Application
Type:
Utility
Filling date:
3 Apr 2018
Issue date:
9 Apr 2020